Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib-Reference-Cited by-同舟云学术

Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib

Published:2015-11-25 Issue:3 Volume:99 Page:274-284
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Jin Y¹,Smith CL²,Hu L¹,Campanale KM¹,Stoltz R³,Huffman LG¹,McNearney TA¹,Yang XY¹,Ackermann BL¹,Dean R¹,Regev A¹,Landschulz W¹

Affiliation:

1. Eli Lilly and Company; Indianapolis Indiana USA

2. Eli Lilly and Company; Lilly UK; Windlesham Surrey UK

3. Covance Clinical Research Unit; Evansville Indiana USA

Funder

Eli Lilly and Company, Indianapolis, IN

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials;Bhala;Lancet,2013

2. Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure;Aw;Arch. Intern. Med.,2005

3. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2;McAdam;Proc. Natl. Acad. Sci. U. S. A.,2005

4. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids;Catella-Lawson;J. Pharmacol. Exp. Ther.,1999

5. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice;Hui;Circulation,2010

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors;Bioorganic Chemistry;2024-06

2. A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's;Rheumatology;2024-01-30

3. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential;Expert Opinion on Therapeutic Targets;2023-11-02

4. Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion;Cancer Research Communications;2023-07-31

5. Pharmacophore-guided drug design using LdNMT as a model drug target for leishmaniasis;Journal of Biomolecular Structure and Dynamics;2023-04-25